Skip to main content
snıff

Rhodesian Ridgeback

Lifespan
12 years
95% CI 11.9 to 12.2 · McMillan 2024, n=2,108
Most carried variant
Cystinuria Type I-A
5.9% of 323 tested · Donner 2023
Behind this page
19 dogs
in the atlas · an early sketch · 323 tested for variants

Rhodesian Ridgebacks have a cited life expectancy of 12 years (McMillan 2024 / VetCompass, n=2,108, 95% CI 11.9 to 12.2). The most carried tested variant is Cystinuria Type I-A, in 5.9% of 323 Rhodesian Ridgebacks tested (Donner 2023), then Degenerative Myelopathy (5.4%) and Bald Thigh Syndrome (3.6%). Only 19 dogs stand behind the atlas figures here, so little is known yet.

Rhodesian Ridgeback
Photo: Bonnie van den Born, http://www.bonfoto.nl · CC BY-SA 3.0 · Wikimedia

Also known as African lion dog and African lion hound.

Mendelian-disease genetics

What genetic diseases do Rhodesian Ridgebacks carry?

From a panel of 250 Mendelian-disease variants screened in 1,054,293 dogs (Donner et al. 2023), Rhodesian Ridgebacks carry 10 of them at observable frequency. Carrier frequency is not clinical risk. Most recessive variants require two copies for disease expression; many dominant variants show incomplete penetrance. Read this as a population fingerprint of what's in the gene pool, not a per-dog prediction.

marker disputed 21.8%
n = 323 dogs · 2 variants tested · OMIA:000162-9615 · omia.org →
PDK4what this gene does

PDK4 helps regulate how cells use energy, especially in the heart muscle.

For your dog: If your dog is one of the breeds known to carry this gene, it’s worth discussing heart health with your vet, but being a carrier doesn’t mean your dog will develop disease.

low 5.9%
n = 323 dogs · 3 variants tested · OMIA:000256-9615 · omia.org →
SLC3A1what this gene does

SLC3A1 is a gene that helps transport certain amino acids in the kidneys. It plays a key role in preventing the buildup of cystine, which can form stones.

For your dog: If your dog is from a breed known to carry SLC3A1 variants, it’s worth discussing cystinuria risks with your vet, especially if urinary issues arise.

Degenerative Myelopathy (DM)
Autosomal recessive (Incomplete penetrance)
low 5.4%
n = 323 dogs · 1 variant tested · OMIA:000263-9615 · omia.org →
SOD1what this gene does

SOD1 is a gene that helps protect cells from damage caused by harmful molecules called free radicals.

For your dog: If your dog is a carrier of SOD1 variants, it's worth discussing with your vet, but remember carrier status doesn't mean your dog will get the disease.

n = 28 dogs · 1 variant tested · OMIA:002168-9615 · omia.org →
IGFBP5what this gene does

IGFBP5 is a gene that helps regulate growth factors involved in tissue development and repair.

For your dog: If you have a sighthound, it’s worth mentioning IGFBP5-related risks to your vet, but being a carrier doesn’t mean your dog will develop the syndrome.

Exercise-Induced Collapse (EIC)
Autosomal recessive (Incomplete penetrance)
low 2.5%
n = 323 dogs · 1 variant tested · OMIA:001466-9615 · omia.org →
DNM1what this gene does

DNM1 is a gene that helps nerve cells communicate properly by managing how they send signals during muscle activity.

For your dog: If your dog belongs to one of the breeds known to carry this gene variant, it's worth discussing EIC with your vet, especially if your dog is very active or shows signs of weakness during exercise.

n = 323 dogs · 1 variant tested · OMIA:001444-9615 · omia.org →
BEST1what this gene does

BEST1 is a gene that helps maintain the health of the retina, the light-sensitive layer at the back of the eye. It plays a role in keeping the cells in the retina functioning properly.

For your dog: If your dog is from a breed known to carry BEST1 variants, it’s worth discussing retinal health with your vet, especially if you notice any vision changes.

n = 323 dogs · 1 variant tested · OMIA:001588-9615 · omia.org →
PNPLA1what this gene does

PNPLA1 is a gene involved in maintaining the skin's barrier by helping produce essential fats that keep the skin healthy and hydrated.

For your dog: If your dog is from a breed known to carry PNPLA1 variants and shows persistent dry, flaky skin, it's worth discussing with your vet to understand if genetics might be playing a role.

n = 323 dogs · 1 variant tested · OMIA:001503-9615 · omia.org →
ARSGwhat this gene does

ARSG is a gene that helps break down certain molecules in the body, keeping cells healthy.

For your dog: If your dog is from a breed known to carry ARSG mutations, it's worth discussing genetic testing with your vet to understand potential health risks.

Source: Donner J et al. 2023. Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651 · Evidence: Limited (DTC ascertainment, tag-SNP proxy) · Confounding MEDIUM · License CC-BY-4.0 · Phene IDs from OMIA (Sydney School of Veterinary Science, The University of Sydney; DOI 10.25910/2AMR-PV70).
Sample size in this breed: 323 dogs from the Donner 2023 cohort.
In plain terms

What these results mean for a Rhodesian Ridgeback

21.8% of Rhodesian Ridgebacks in the Donner 2023 cohort carried it (n=323).

  • This is a marker, not an established cause. The curated record says a test based on it is not a good indicator of heart disease risk even in Dobermans, the breed it was found in.
    OMIA 000162-9615

    “it is evident that any DNA test based on this marker will not be a good indicator of liability to this disorder in Dobermans” OMIA 000162-9615

What to do
A carrier result for this marker is not, on its own, a reason for heart screening. Heart screening is a conversation with your veterinarian about the breed and the dog.

No test, or a mix
What this marker means in breeds other than the Doberman is not established in the sources this page draws on.

5.9% of Rhodesian Ridgebacks in the Donner 2023 cohort carried it (n=323).

  • The kidneys fail to reclaim an amino acid called cystine, which can form crystals and stones in the urine and block the urinary tract.
    OMIA 000256-9615

    “Cystinuria, type 1 - A is an inherited defect that causes failure of reabsorption of cystine in the proximal renal tubule, leading to cystine precipitation in the urine. Formation of crystals and calculi lead to urolithiasis and urinary tract obstruction.” OMIA 000256-9615

What to do
Straining to urinate, or passing little or no urine, needs a veterinarian the same day.

No test, or a mix
Without a test nobody can say how many copies a dog has.

5.4% of Rhodesian Ridgebacks in the Donner 2023 cohort carried it (n=323).

  • DM is a loss of function in the spinal cord that begins in adulthood and progresses to paralysis of the back legs. There is no treatment that stops it.
    OMIA 000263-9615

    “This is an adult onset degeneration of the spinal cord that progresses to paraplegia and tetraparesis. There is no successful treatment. A genetic test is available.” OMIA 000263-9615

  • Two copies of the SOD1 variant mean at risk, not affected. Some dogs with two copies never show signs.
    OMIA 000263-9615

    “some homozygous mutant dogs had no signs of degenerative myelopathy, which suggests incomplete penetrance or other causative loci” OMIA 000263-9615

  • One copy makes a dog a carrier. In the study that found the variant, every affected dog tested had two copies.
    OMIA 000263-9615

    “All affected dogs tested were homozygous mutant.” OMIA 000263-9615

What to do
A DNA result is not a diagnosis. Take the result, and any change in how the dog walks, to a veterinarian.

No test, or a mix
Without a test nobody can say how many copies a dog has. A breed's carrier frequency describes the breed, not this dog.

Which Mendelian variants matter most for Rhodesian Ridgebacks?

The Mendelian-disease table above lists variants screened in 323 Rhodesian Ridgebacks (Donner 2023). Two matter most by impact, and the first one is urgent to understand.

What should I feed a Rhodesian Ridgeback?

Joint care is secondary but real. The OFA reports hip dysplasia rates for evaluated Ridgebacks at ofa.org/diseases/hip-dysplasia, and the breed’s size means early-life bone development needs precision. A large-breed puppy formulation with controlled calcium and a calcium-to-phosphorus ratio between 1.1:1 and 2:1 supports skeletal development without over-supplementation (NRC 2006). Adult-life weight management protects the spine in dogs at DM risk.

Protein and amino acid balance matter for neurological support. Dogs at risk for degenerative myelopathy benefit from complete amino acid profiles with adequate methionine and cysteine. A high-quality protein source (animal-based rather than plant-based as the primary protein) is a reasonable choice here, though the evidence for prevention of DM onset is not yet definitive.

The breed’s cystinuria carriers are managed with low-protein, alkalinizing diets if they form stones; this is individualized management, not a breed-wide rule. Consult your veterinarian if a Ridgeback has a history of urinary calculi.

What we don’t know

The exercise-induced collapse variant shows zero phenotype confirmation in the Donner cohort (0/2 at-risk dogs), so the clinical significance of this variant in Ridgebacks is still uncertain. Similarly, the CMR1 retinal variant shows zero phenotype confirmation (0/1 at-risk dog). These may be important variants or incidental findings; we do not yet have enough clinical data to say.

The Donner cohort for Ridgebacks is 323 dogs, which is smaller than some of the larger breeds in the study. Rare variants may not be captured, and the confidence intervals around the carrier frequencies are wider than in the largest breeds.

Frequently asked questions about Rhodesian Ridgebacks

How long do Rhodesian Ridgebacks live? The breed’s median lifespan is often cited as approximately 10 to 12 years by breed clubs, consistent with large-breed longevity (Rhodesian Ridgeback Club of the United States, rhrc.org). Individual dogs show substantial variation based on genetics, diet, and management of any cardiac or neurological conditions.

What should I feed a Rhodesian Ridgeback? A grain-inclusive, taurine-supplemented large-breed adult formulation from a manufacturer that runs feeding trials is the conservative default, especially for dogs at cardiac risk. Avoid grain-free diets unless your vet recommends one for specific gastrointestinal disease. Puppy formulations should maintain calcium-to-phosphorus ratios between 1.1:1 and 2:1 (NRC 2006).

Are Rhodesian Ridgebacks good family dogs? Yes. The breed is stable and tolerant with children and other dogs. They are single-prey-drive hunters originally, so socialization with smaller pets should start early. Their size and strength mean supervision with small children is important.

Do Rhodesian Ridgebacks have a ridge on their back? Yes. The ridge is the breed’s signature trait, a stripe of hair running forward along the spine. It is a dominant trait and is present in nearly all Ridgebacks. The ridge itself is a cosmetic trait, though a related condition called dermoid sinus can occur along the ridge line and should be checked by a veterinarian in puppies.

Temperament

What Rhodesian Ridgebacks tend toward

Tendencies from owner surveys of purebred Rhodesian Ridgebacks — a leaning across the breed, not a prediction for any one dog. A bar’s strength shows how much of that behavior breed actually explains: for most it’s faint, because the rest is your dog, their training, and the life you give them.

Biddabilitybreed ~18%
biddableindependent
n = 25 dogs · Morrill et al. 2022, Science, Darwin's Ark (CC0)
Owner-reported purebreds; each factor n ≥ 25. "Breed ~%" is the share of this behavior explained by breed.
Names & origins

Other names

The Rhodesian Ridgeback is also recorded as African lion dog and African lion hound.

Identified as Rhodesian Ridgeback (VBO:0201135) in the Vertebrate Breed Ontology (Mullen et al. 2025, CC-BY 4.0) · registry IDs FCI 146 · iDog 204 · VeNom 14634.

For researchers Population genetics, disease models and every recorded condition Open the research detail for the Rhodesian Ridgeback
What the atlas says about Rhodesian Ridgeback

In the atlas, the Rhodesian Ridgeback clusters consistently as Rhodesian Ridgeback (100% of the 19 dogs here). Dogs here sit in a relatively sparse region of the atlas, fewer close neighbors than typical.

Low breed predictability score (0.17), individual dogs of this breed vary widely in genetics, suggesting active substructure or sub-population diversity. Only 19 dogs of this breed in the atlas, modestly sampled.

Genetic dimensions · CanVAS atlas

What the atlas genotypes say about Rhodesian Ridgeback

Computed from the 14,478 CanVAS dogs in the Atlas, on an imputed genotype backbone: 77,215 directly typed sites per dog, imputed to 9.67 million variants.

The confidence below counts dogs, not reads: it is the size of the sample, and it is separate from how the genotypes were measured.

These figures are computed from only 19 Rhodesian Ridgebacks in the atlas. Treat them as provisional. They sharpen as more dogs are added.
Dogs in the Atlas
19Founders
10 from Hayward2016, 9 from Spatola
Genetic diversity

Not enough dogs in the atlas yet (n=19) for a reliable diversity figure. It fills in as more are added.

Mean heterozygosity across the breed. Too few dogs in this breed (<20) to rank.
What does genetic diversity mean?

How varied a breed's gene pool is — the share of gene spots where a typical dog of the breed carries two different versions rather than two identical ones.

How to read it: Higher = more diverse. Among well-sampled breeds it ranges roughly 0.22 (least diverse) to 0.33 (most diverse).

Diversity is a strength, not a verdict on any individual dog. Lower diversity means it's worth paying attention to recessive-risk testing — not that a dog is doomed.

Cluster structure

Not enough dogs in the atlas yet (n=19) to resolve cluster structure. It fills in as more are added.

What does within-breed variation mean?

How much individual dogs within the breed differ from each other genetically.

How to read it: Higher = more internal variety among individuals of the breed.

Sensitive to how many dogs of the breed we've sampled.

Related breeds
Built from
Close cousins
In the Working group
Explore the full lineage map →
VBO foundation stock (breeding records) · AKC breed group
Relatedness is documented lineage + kennel family. Genetic-ancestry distance measures diversity, not kinship, so it isn't used here.
How long they live
12years (life expectancy)
95% CI 11.9–12.2 · VetCompass, McMillan 2024, n=2,108. source
What does typical lifespan mean?

The median age dogs of the breed tend to reach.

How to read it: Higher = longer-lived. Compare to longevity-for-size to see whether it's just a size effect.

Drawn from population lifespan records; individual dogs vary widely with care, genetics, and luck.

n = 19 dogs · low sample · CanVAS (Brundage 2026) · Sniff Atlas
A gift to human medicine

Rhodesian Ridgebacks are a natural model for human disease

Because the same genes cause the same conditions across species, the inherited conditions documented in Rhodesian Ridgebacks help researchers understand, and work toward treating, the human diseases they model. This is the dog advancing human medicine. The breed models the human disease; it does not have it, and this is not a prediction for your dog.

Human equivalents via OMIA → Mondo / OMIM. Model-of, not identity. The named gene is the canine locus, not a claim that a pet has the human disease.
Documented in OMIA

Every condition recorded in the Rhodesian Ridgeback

Beyond the testable carriers above, OMIA's literature catalogue records 12 genetic conditions in the Rhodesian Ridgeback, 11 of which have a known human equivalent. This is the documented landscape across all Rhodesian Ridgebacks ever studied, not a prediction for any one dog.

Online Mendelian Inheritance in Animals (OMIA); Nicholas, Tammen & Sydney Informatics Hub, DOI 10.25910/2AMR-PV70
Documented in the breed's literature is not carrier status and not a forecast for an individual dog. Human equivalents are mapped via Mondo/OMIM. Carrier frequencies (above) are the separately-measured testable subset (Donner 2023).
The data behind this page

Where every number on this page came from.

This page draws on three primary data sources. Carrier frequencies for the Mendelian section come from Donner et al. 2023 (CC-BY-4.0). We grade these data at evidence Limited because the cohort is a direct-to-consumer ascertainment, which biases toward owners who chose to test their dogs. The panel also uses tag-SNP proxies for some variants rather than direct causal-variant assays. Limited is a study-design grade, not a quality grade: the Donner cohort is the largest open canine-genotype dataset in existence and we are grateful for it. We rate the confounding MEDIUM.

Population-genetic dimensions (heterozygosity, intra-breed PCA distance, nearest neighbors, trait-locus frequencies) come from CanVAS (Brundage 2026), harmonized through the Sniff Atlas. The exact release date and verification commit are pinned at the bottom of the page so a researcher can trace a number back to a specific snapshot. The disease-gene-variant graph comes from OMIA (Online Mendelian Inheritance in Animals; Nicholas, Tammen, and the Sydney Informatics Hub at the Sydney School of Veterinary Science, The University of Sydney; retrieved April 2026, DOI 10.25910/2AMR-PV70).

What this page does not yet have. Inheritance modes and per-disease penetrance evidence from Donner 2023 are in the structured data for every variant the panel covers. Mondo, OMIM, Ensembl, and HGNC cross-references live on the gene and disease pages this page links to, rather than being repeated here. What is still absent from this breed page is anything not in the cited panel, and each such gap carries its cause where it appears.

How to cite this page. The computed dimensions on this page are derived from the open Sniff Atlas v1.0.1 (Gehring 2026, doi:10.5281/zenodo.20566358, CC-BY 4.0). Full citation formats including BibTeX, RIS, and CITATION.cff at sniff.world/cite.

Some things about living with a rhodesian ridgeback never make it into a database. Add what you know as a Keeper, in your words →

Lived experience, kept beside the science.
Add your rhodesian ridgeback to the atlas

We have 19 rhodesian ridgebacks. We do not have yours.

Close to a cited number

We can already place this breed on the atlas. We hold genetic diversity for n=19 of this breed in the atlas. Our floor for showing a cited rate is n=20. That is 1 more of this breed in our atlas, not in a published study.

Adding your dog is 1 of those 1 in the Sniff atlas cohort. Adding them is free and permanent.

Enrollment is free. The data stays open. The star is permanent.

Want to wait for DNA uploads?

Leave your email and we'll let you know the moment DNA uploads open for Rhodesian Ridgebacks.

References
  1. Donner J, Freyer J, Davison S, Anderson H, Blades M, Honkanen L, et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651. doi:10.1371/journal.pgen.1010651
  2. Brundage DM (2026). CanVAS: A Harmonized and Imputed Canine Variant Atlas. bioRxiv. doi:10.64898/2026.04.13.718238
  3. Nicholas, F.W., Tammen, I., & Sydney Informatics Hub. (2026). Online Mendelian Inheritance in Animals (OMIA) [dataset]. The University of Sydney. https://omia.org. doi:10.25910/2AMR-PV70 (retrieved April 2026).
Last updated
Sources: CanVAS (Brundage 2026) · Donner 2023 · OMIA